Atlas Trials

Perfusion CT as a Predictor for Response to Antiangiogenic Therapy in Patients With Metastasized Renal Cell Carcinoma

Clinical trial NCT02086734 · COMPLETED

Trial details

NCT number
NCT02086734
Sponsor
Ludwig-Maximilians - University of Munich
Status
COMPLETED
Study type
OBSERVATIONAL
Metastatic Renal Cancer
Start date
2012-04-01
Primary completion
2018-07-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.